Shoshana V. Aronowitz

924 total citations
47 papers, 522 citations indexed

About

Shoshana V. Aronowitz is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and General Health Professions. According to data from OpenAlex, Shoshana V. Aronowitz has authored 47 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Public Health, Environmental and Occupational Health, 24 papers in Epidemiology and 8 papers in General Health Professions. Recurrent topics in Shoshana V. Aronowitz's work include Opioid Use Disorder Treatment (29 papers), Substance Abuse Treatment and Outcomes (19 papers) and HIV, Drug Use, Sexual Risk (15 papers). Shoshana V. Aronowitz is often cited by papers focused on Opioid Use Disorder Treatment (29 papers), Substance Abuse Treatment and Outcomes (19 papers) and HIV, Drug Use, Sexual Risk (15 papers). Shoshana V. Aronowitz collaborates with scholars based in United States, United Kingdom and France. Shoshana V. Aronowitz's co-authors include Teri Aronowitz, Rachel French, Jennifer Laurent, Boram Kim, Eugenia C. South, Margaret Lowenstein, Peggy Compton, Utsha G. Khatri, Zachary F. Meisel and Heath D. Schmidt and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Public Health and Journal of General Internal Medicine.

In The Last Decade

Shoshana V. Aronowitz

40 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoshana V. Aronowitz United States 16 312 212 109 64 60 47 522
Rachel Simon United States 9 242 0.8× 216 1.0× 115 1.1× 44 0.7× 80 1.3× 14 506
George Karandinos United States 8 395 1.3× 320 1.5× 63 0.6× 88 1.4× 47 0.8× 16 596
Lucas G. Hill United States 16 512 1.6× 287 1.4× 71 0.7× 18 0.3× 37 0.6× 46 653
Dana Quesinberry United States 8 342 1.1× 169 0.8× 64 0.6× 16 0.3× 83 1.4× 19 501
Brandon Muncan United States 7 170 0.5× 265 1.3× 102 0.9× 52 0.8× 39 0.7× 15 427
Catherine Paquette United States 9 282 0.9× 433 2.0× 122 1.1× 60 0.9× 68 1.1× 38 623
Karol Krotki United States 10 185 0.6× 132 0.6× 95 0.9× 94 1.5× 48 0.8× 20 471
Alexandria Macmadu United States 17 472 1.5× 463 2.2× 127 1.2× 114 1.8× 87 1.4× 44 760
Colleen LaBelle United States 13 655 2.1× 666 3.1× 211 1.9× 29 0.5× 62 1.0× 21 941
Elizabeth Needham Waddell United States 14 219 0.7× 216 1.0× 185 1.7× 45 0.7× 32 0.5× 37 532

Countries citing papers authored by Shoshana V. Aronowitz

Since Specialization
Citations

This map shows the geographic impact of Shoshana V. Aronowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoshana V. Aronowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoshana V. Aronowitz more than expected).

Fields of papers citing papers by Shoshana V. Aronowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoshana V. Aronowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoshana V. Aronowitz. The network helps show where Shoshana V. Aronowitz may publish in the future.

Co-authorship network of co-authors of Shoshana V. Aronowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Shoshana V. Aronowitz. A scholar is included among the top collaborators of Shoshana V. Aronowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoshana V. Aronowitz. Shoshana V. Aronowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lowenstein, Margaret, et al.. (2025). Real-world access to buprenorphine treatment in Philadelphia: A secret shopper study. Drug and Alcohol Dependence. 268. 112586–112586.
2.
3.
4.
French, Rachel, Nicole H. O’Donnell, Jeanmarie Perrone, et al.. (2025). A qualitative study exploring the feasibility and acceptability of embedding an overdose prevention sites in a U.S. hospital. Journal of Substance Use and Addiction Treatment. 170. 209620–209620.
5.
Aronowitz, Shoshana V., et al.. (2025). Patient and Provider Experiences With Opioid Use Disorder Care Delivered via Telehealth: A Systematic Mixed-Studies Review. Drug and Alcohol Dependence. 267. 111999–111999.
6.
Aronowitz, Shoshana V., et al.. (2025). Scaling up low barrier wound care for people who use drugs: a mixed methods study. Harm Reduction Journal. 22(1). 84–84.
7.
Aronowitz, Shoshana V., et al.. (2024). Barriers and facilitators to implementing CareConnect: A telehealth, low-barrier buprenorphine bridge clinic in Philadelphia. International Journal of Drug Policy. 133. 104569–104569. 4 indexed citations
8.
Aronowitz, Shoshana V., et al.. (2024). Mapping Buprenorphine Access at Philadelphia Pharmacies. Journal of Addiction Medicine. 18(3). 269–273. 1 indexed citations
9.
Aronowitz, Shoshana V., et al.. (2024). Patient and provider experiences with opioid use disorder care delivered via telehealth: A systematic mixed-studies review. Drug and Alcohol Dependence. 266. 112522–112522.
10.
11.
Friedman, Joseph, Philippe Bourgois, Shoshana V. Aronowitz, et al.. (2023). Rethinking urban-rural designations in public health surveillance of the overdose crisis and crafting an agenda for future monitoring. International Journal of Drug Policy. 118. 104072–104072. 1 indexed citations
12.
Piltch‐Loeb, Rachael, Richard James, Sandra S. Albrecht, et al.. (2023). What Were the Information Voids? A Qualitative Analysis of Questions Asked by Dear Pandemic Readers between August 2020-August 2021. Journal of Health Communication. 28(sup1). 25–33. 2 indexed citations
13.
Lowenstein, Margaret, et al.. (2023). “Come try it out. Get your foot in the door:” Exploring patient perspectives on low-barrier treatment for opioid use disorder. Drug and Alcohol Dependence. 248. 109915–109915. 9 indexed citations
14.
Ferguson, Aaron, Mary Figgatt, Shoshana V. Aronowitz, et al.. (2023). Reducing the harms of xylazine: clinical approaches, research deficits, and public health context. Harm Reduction Journal. 20(1). 141–141. 44 indexed citations
15.
Aronowitz, Shoshana V., et al.. (2022). Problematizing “patient stability” in opioid use disorder care: Flexible definitions, (in)flexible treatment. International Journal of Drug Policy. 108. 103804–103804. 2 indexed citations
16.
Aronowitz, Shoshana V., et al.. (2021). “We have to be uncomfortable and creative”: Reflections on the impacts of the COVID-19 pandemic on overdose prevention, harm reduction & homelessness advocacy in Philadelphia. SHILAP Revista de lepidopterología. 1. 100013–100013. 19 indexed citations
17.
French, Rachel, et al.. (2021). A free mailed naloxone program in Philadelphia amidst the COVID-19 pandemic. International Journal of Drug Policy. 94. 103199–103199. 23 indexed citations
18.
Aronowitz, Shoshana V., Frances S. Shofer, Max Jordan Nguemeni Tiako, et al.. (2021). Patient Preference and Risk Assessment in Opioid Prescribing Disparities. JAMA Network Open. 4(7). e2118801–e2118801. 17 indexed citations
19.
Aronowitz, Shoshana V., Peggy Compton, & Heath D. Schmidt. (2020). Innovative Approaches to Educating Future Clinicians about Opioids, Pain, Addiction and Health Policy. Pain Management Nursing. 22(1). 11–14. 9 indexed citations
20.
Aronowitz, Shoshana V. & Jennifer Laurent. (2016). Screaming Behind a Door. Journal of Correctional Health Care. 22(2). 98–108. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachel Simon Breakdown of academic impact, for papers by George Karandinos Breakdown of academic impact, for papers by Lucas G. Hill Breakdown of academic impact, for papers by Dana Quesinberry Breakdown of academic impact, for papers by Brandon Muncan Breakdown of academic impact, for papers by Catherine Paquette Breakdown of academic impact, for papers by Karol Krotki Breakdown of academic impact, for papers by Alexandria Macmadu Breakdown of academic impact, for papers by Colleen LaBelle Breakdown of academic impact, for papers by Elizabeth Needham Waddell
Rankless by CCL
2026